PMID- 21900085 OWN - NLM STAT- MEDLINE DCOM- 20111115 LR - 20191210 IS - 1524-4539 (Electronic) IS - 0009-7322 (Linking) VI - 124 IP - 12 DP - 2011 Sep 20 TI - Role of cardiovascular magnetic resonance as a gatekeeper to invasive coronary angiography in patients presenting with heart failure of unknown etiology. PG - 1351-60 LID - 10.1161/CIRCULATIONAHA.110.011346 [doi] AB - BACKGROUND: In patients presenting with new-onset heart failure of uncertain etiology, the role of coronary angiography (CA) is unclear. Although conventionally performed to differentiate underlying coronary artery disease from dilated cardiomyopathy, CA is associated with a risk of complications and may not detect an ischemic cause resulting from arterial recanalization or an embolic episode. In this study, we assessed the diagnostic accuracy of a cardiovascular magnetic resonance (CMR) protocol incorporating late gadolinium enhancement (LGE) and magnetic resonance CA as a noninvasive gatekeeper to CA in determining the etiology of heart failure in this subset of patients. METHODS AND RESULTS: One hundred twenty consecutive patients underwent CMR and CA. The etiology was ascribed by a consensus panel that used the results of the CMR scans. Similarly, a separate consensus group ascribed an underlying cause by using the results of CA. The diagnostic accuracy of both strategies was compared against a gold-standard panel that made a definitive judgment by reviewing all clinical data. The study was powered to show noninferiority between the 2 techniques. The sensitivity of 100%, specificity of 96%, and diagnostic accuracy of 97% for LGE-CMR were equivalent to CA (sensitivity, 93%; specificity, 96%; and diagnostic accuracy, 95%). As a gatekeeper to CA, LGE-CMR was also found to be a cheaper diagnostic strategy in a decision tree model when United Kingdom-based costs were assumed. The economic merits of this model would change, depending on the relative costs of LGE-CMR and CA in any specific healthcare system. CONCLUSION: This study showed that LGE-CMR is a safe, clinically effective, and potentially economical gatekeeper to CA in patients presenting with heart failure of uncertain etiology. FAU - Assomull, Ravi G AU - Assomull RG AD - Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK. FAU - Shakespeare, Carl AU - Shakespeare C FAU - Kalra, Paul R AU - Kalra PR FAU - Lloyd, Guy AU - Lloyd G FAU - Gulati, Ankur AU - Gulati A FAU - Strange, Julian AU - Strange J FAU - Bradlow, William M AU - Bradlow WM FAU - Lyne, Jonathan AU - Lyne J FAU - Keegan, Jennifer AU - Keegan J FAU - Poole-Wilson, Philip AU - Poole-Wilson P FAU - Cowie, Martin R AU - Cowie MR FAU - Pennell, Dudley J AU - Pennell DJ FAU - Prasad, Sanjay K AU - Prasad SK LA - eng GR - British Heart Foundation/United Kingdom PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Validation Study DEP - 20110906 PL - United States TA - Circulation JT - Circulation JID - 0147763 RN - AU0V1LM3JT (Gadolinium) SB - IM CIN - Circulation. 2012 Jun 19;125(24):e1041; author reply e1042. PMID: 22711673 MH - Aged MH - Cardiac Imaging Techniques/economics/*standards/statistics & numerical data MH - *Coronary Angiography/economics MH - Decision Trees MH - Female MH - Follow-Up Studies MH - Gadolinium MH - Health Care Costs MH - Heart Failure/*diagnosis/economics/*etiology MH - Humans MH - Magnetic Resonance Imaging/economics/*standards/statistics & numerical data MH - Male MH - Middle Aged MH - Observer Variation MH - Referral and Consultation/economics/standards/statistics & numerical data MH - Reproducibility of Results MH - Sensitivity and Specificity MH - United Kingdom EDAT- 2011/09/09 06:00 MHDA- 2011/11/16 06:00 CRDT- 2011/09/09 06:00 PHST- 2011/09/09 06:00 [entrez] PHST- 2011/09/09 06:00 [pubmed] PHST- 2011/11/16 06:00 [medline] AID - CIRCULATIONAHA.110.011346 [pii] AID - 10.1161/CIRCULATIONAHA.110.011346 [doi] PST - ppublish SO - Circulation. 2011 Sep 20;124(12):1351-60. doi: 10.1161/CIRCULATIONAHA.110.011346. Epub 2011 Sep 6.